Bruce Conklin, MD, and his team at Gladstone Institutes are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.

Using cells collected from patients with CMT, the scientists are exploring ways to use gene editing as a therapeutic tool to treat the disease.

In this video, Bruce Conklin and Bria Macklin describe their work and explain how it could help patients like Jeremy, an energetic 5-year-old who donated his cells to Gladstone for this research.

Content note: The narration in the first 6 seconds of this video was enhanced using an AI-generated voice.

Featured Experts

Gladstone NOW: The Campaign
 Join Us On The Journey

Up Next


Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

Science in Seconds with Deepak Srivastava
Video November 3, 2025

Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

In this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCs

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

Science in Seconds featuring Steve Finkbeiner
Video October 15, 2025

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

In this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data

More News